KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesPension (IS)Profit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Colgate Palmolive (CL) EBITDA (2016 - 2025)

Colgate Palmolive has reported EBITDA over the past 17 years, most recently at $92.0 million for Q4 2025.

  • Quarterly results put EBITDA at $92.0 million for Q4 2025, down 91.35% from a year ago — trailing twelve months through Dec 2025 was $3.3 billion (down 22.5% YoY), and the annual figure for FY2025 was $3.3 billion, down 22.54%.
  • EBITDA for Q4 2025 was $92.0 million at Colgate Palmolive, down from $1.1 billion in the prior quarter.
  • Over the last five years, EBITDA for CL hit a ceiling of $1.1 billion in Q2 2024 and a floor of $92.0 million in Q4 2025.
  • Median EBITDA over the past 5 years was $1.0 billion (2021), compared with a mean of $889.2 million.
  • Biggest five-year swings in EBITDA: soared 430.69% in 2023 and later plummeted 91.35% in 2025.
  • Colgate Palmolive's EBITDA stood at $365.0 million in 2021, then plummeted by 44.66% to $202.0 million in 2022, then soared by 430.69% to $1.1 billion in 2023, then dropped by 0.84% to $1.1 billion in 2024, then plummeted by 91.35% to $92.0 million in 2025.
  • The last three reported values for EBITDA were $92.0 million (Q4 2025), $1.1 billion (Q3 2025), and $1.1 billion (Q2 2025) per Business Quant data.